January 4, 2024

Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline

Potential First-in-Class Novel Molecule with Novel Target In-Licensed from Collaboration with Bayer SALT LAKE CITY, Jan. 04, 2024 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has signed an agreement with Bayer AG to in-license a new chemical entity that emerged from […]

Dr. N. Krishna Reddy appointed CEO and Dr. Sten Vermund inducted to ACCESS Health International’s Board of Directors

HYDERABAD, INDIA – Media OutReach Newswire – 4 January 2024 – ACCESS Health International, a globally recognized health systems think tank and advisory group, today announced two important leadership transitions. Dr. N. Krishna Reddy, who has been leading the operations as President across Asia, Middle East, and North Africa, has been appointed Chief Executive Officer. Concurrently, the organization […]